MacroGenics | MGNX - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 14.39B 1.85B 2026-06
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Biogen USD 2.12B 307M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Eli Lilly USD 16.22B 301.7M 2026-03
Genmab DKK 1.07B 240M 2026-06
Geron USD 50.14M 3.44M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
J&J USD 18.55B 6M 2026-09
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
MacroGenics USD 11.24M 19.87M 2026-03
Merck USD 12.09B 1.24B 2026-03
Pfizer USD -248M 11.29B 2026-06
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Xencor USD 51.22M 46.7M 2026-06